Recherche - Université de Picardie Jules Verne Accéder directement au contenu

Filtrer vos résultats

5 Résultats
Structure : Identifiant HAL de la structure : 322686

LBA33 5-year overall survival (OS) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) treated with xevinapant + chemoradiotherapy (CRT) vs placebo + CRT in a randomized, phase II study

J. Bourhis , C. Le Tourneau , B. Calderon , L. Martin , C. Sire , et al.
Annals of Oncology, 2022, 33, pp.S1400. ⟨10.1016/j.annonc.2022.08.030⟩
Article dans une revue hal-03911292v1
Image document

TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial

Cyrille Féray , Loic Campion , Philippe Mathurin , Isabelle Archambreaud , Xavier Mirabel , et al.
JHEP Reports Innovation in Hepatology, 2023, 5 (4), pp.100689. ⟨10.1016/j.jhepr.2023.100689⟩
Article dans une revue hal-04044132v1

A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy

Laurent Zelek , Philippe Debourdeau , Hugues Bourgeois , Jean Philippe Wagner , Fabien Brocard , et al.
Oncologist, 2021, 26 (10), pp.E1870-E1879. ⟨10.1002/onco.13888⟩
Article dans une revue hal-03598654v1

Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial

Yungan Tao , Xu-Shan Sun , Yoann Pointreau , Christophe Le Tourneau , Christian Sire , et al.
European Journal of Cancer, 2023, 183, pp.24-37. ⟨10.1016/j.ejca.2022.12.015⟩
Article dans une revue hal-04002440v1

Practical and technical key challenges in head and neck adaptive radiotherapy: The GORTEC point of view

Nolwenn Delaby , Anaïs Barateau , Sophie Chiavassa , Marie-Claude Biston , Philippe Chartier , et al.
Physica Medica, 2023, 109, pp.102568. ⟨10.1016/j.ejmp.2023.102568⟩
Article dans une revue hal-04061410v1